237 related articles for article (PubMed ID: 25399653)
1. Treatment of drug-resistant Shigella infections.
Klontz KC; Singh N
Expert Rev Anti Infect Ther; 2015 Jan; 13(1):69-80. PubMed ID: 25399653
[TBL] [Abstract][Full Text] [Related]
2. Changing patterns of drug-resistant Shigella isolates in egypt.
Abd-Elmeged GM; Khairy RM; Abo-Eloyoon SM; Abdelwahab SF
Microb Drug Resist; 2015 Jun; 21(3):286-91. PubMed ID: 25495749
[TBL] [Abstract][Full Text] [Related]
3. Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014.
Nüesch-Inderbinen M; Heini N; Zurfluh K; Althaus D; Hächler H; Stephan R
Emerg Infect Dis; 2016 Jun; 22(6):1083-5. PubMed ID: 27191035
[TBL] [Abstract][Full Text] [Related]
4. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.
Rahman M; Shoma S; Rashid H; El Arifeen S; Baqui AH; Siddique AK; Nair GB; Sack DA
J Health Popul Nutr; 2007 Jun; 25(2):158-67. PubMed ID: 17985817
[TBL] [Abstract][Full Text] [Related]
5. Response to antimicrobial therapy for shigellosis in Thailand.
Lolekha S; Vibulbandhitkit S; Poonyarit P
Rev Infect Dis; 1991; 13 Suppl 4():S342-6. PubMed ID: 2047660
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-Resistant Shigella Infections in Patients with Diarrhea, Cambodia, 2014-2015.
Poramathikul K; Bodhidatta L; Chiek S; Oransathid W; Ruekit S; Nobthai P; Lurchachaiwong W; Serichantalergs O; Lon C; Swierczewski B
Emerg Infect Dis; 2016 Sep; 22(9):1640-3. PubMed ID: 27532684
[TBL] [Abstract][Full Text] [Related]
7. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.
Niyogi SK
Clin Microbiol Infect; 2007 Dec; 13(12):1141-3. PubMed ID: 17953700
[TBL] [Abstract][Full Text] [Related]
8. Death from multi-resistant shigellosis in Fiji Islands.
Watson C
Pac Health Dialog; 2001 Mar; 8(1):99-102. PubMed ID: 12017845
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and antibiotic resistance of Shigella gastroenteritis in Ankara, Turkey between 2003 and 2009, and comparison with previous reports.
Özmert EN; İnce OT; Örün E; Yalçın S; Yurdakök K; Gür D
Int J Infect Dis; 2011 Dec; 15(12):e849-53. PubMed ID: 21982814
[TBL] [Abstract][Full Text] [Related]
11. Emergence of antibiotic resistant Shigella species: A matter of concern.
Puzari M; Sharma M; Chetia P
J Infect Public Health; 2018; 11(4):451-454. PubMed ID: 29066021
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of tigecycline and other antimicrobial agents against Shigella species from Kuwait and the United Arab of Emirates.
Jamal W; Rotimi VO; Pal T; Sonnevend A; Dimitrov TS
J Infect Public Health; 2010; 3(1):35-42. PubMed ID: 20701889
[TBL] [Abstract][Full Text] [Related]
13. Emergence of antimicrobial-resistant shigellosis in Oregon.
Replogle ML; Fleming DW; Cieslak PR
Clin Infect Dis; 2000 Mar; 30(3):515-9. PubMed ID: 10722437
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of Shigella isolates in eight Asian countries, 2001-2004.
Kuo CY; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; Van PH; Chongthaleong A; Song JH; Chiu CH
J Microbiol Immunol Infect; 2008 Apr; 41(2):107-11. PubMed ID: 18473096
[TBL] [Abstract][Full Text] [Related]
15. Trends in antimicrobial resistance in Shigella species in Karachi, Pakistan.
Khan E; Jabeen K; Ejaz M; Siddiqui J; Shezad MF; Zafar A
J Infect Dev Ctries; 2009 Dec; 3(10):798-802. PubMed ID: 20009283
[TBL] [Abstract][Full Text] [Related]
16. The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America.
Barrantes K; Achí R
Braz J Microbiol; 2016; 47(4):800-806. PubMed ID: 27528086
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance of Shigella spp. from humans in Shanghai, China, 2004-2011.
Zhang J; Jin H; Hu J; Yuan Z; Shi W; Yang X; Xu X; Meng J
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):282-6. PubMed ID: 24387959
[TBL] [Abstract][Full Text] [Related]
18. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993.
Lima AA; Lima NL; Pinho MC; Barros Juñior EA; Teixeira MJ; Martins MC; Guerrant RL
Antimicrob Agents Chemother; 1995 Jan; 39(1):256-9. PubMed ID: 7695319
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for Travel and Domestically Acquired Multidrug-Resistant Human Shigella Infections-Pennsylvania, 2006-2014.
Li YL; Tewari D; Yealy CC; Fardig D; M'ikanatha NM
Health Secur; 2016; 14(3):143-51. PubMed ID: 27314654
[TBL] [Abstract][Full Text] [Related]
20. Magnitude of drug resistant Shigellosis: a report from Bangalore.
Srinivasa H; Baijayanti M; Raksha Y
Indian J Med Microbiol; 2009; 27(4):358-60. PubMed ID: 19736408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
